Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Pharco Pharma NV/SA sfrutta i vantaggi del Cloud Computing implementando Veeva CRM


News provided by

Veeva Systems

Sep 14, 2011, 01:00 ET

Share this article

Share toX

Share this article

Share toX

BARCELLONA, September 14, 2011 /PRNewswire/ --

Pharco Pharma NV/SA, un'azienda farmaceutica in rapida crescita e specializzata in farmaci prescrivibili, farmaci da banco e supplementi alimentari, ha implementato Veeva CRM per supportare la propria struttura di vendita in Belgio. Pharco era alla ricerca di un'applicazione di Customer Relationship Management (CRM) economica e intuitiva, che fosse specifica per il settore farmaceutico e, allo stesso tempo, facilmente adattabile. L'azienda si è rivolta a Veeva CRM, la soluzione leader basata su tecnologia cloud per il settore mondiale della farmaceutica e delle biotecnologie.

Pharco ha scelto Veeva CRM dopo anni di problemi con soluzioni sbagliate. Nel 2007, scontenta dei costi elevati, della rigidità e della scarsa adozione della sua soluzione automatizzata di CRM esistente, la società ha fatto una mossa coraggiosa e l'ha abbandonata, tornando a "carta e penna". Il sistema manuale, che è stato sempre considerato una soluzione temporanea, non era in grado di fornire al management visibilità sull'efficacia della forza vendite, né era sufficientemente pratico per gestire la rapida crescita dell'azienda.

"Conoscendo bene i pericoli legati alla scelta del partner sbagliato, siamo stati particolarmente attenti nel condurre le nostre ricerche," spiega Karel Goderis, Direttore Generale di Pharco. "Eravamo alla ricerca di una soluzione CRM basata su tecnologia cloud, progettata per il settore farmaceutico, semplice da usare, economicamente vantaggiosa e sufficientemente flessibile per crescere insieme alla nostra organizzazione. Veeva è stata l'unica soluzione a soddisfare completamente tutti i nostri criteri".  

"La soluzione Veeva CRM ha già dimostrato di poter sostenere il nostro tasso di crescita annuale del 40 percento, è stata rapida da implementare e ci ha risparmiato la spesa relativa all'installazione e gestione di un'infrastruttura IT interna," continua Goderis.

Veeva Systems è divenuta rapidamente un leader globale nella fornitura di soluzioni CRM per il settore farmaceutico. Grazie alla piattaforma cloud, Veeva CRM non richiede componenti hardware o software da acquistare, scalare o mantenere. Inoltre, tutti i clienti di Veeva ricevono aggiornamenti automatici gratuiti, quindi gli utenti utilizzano sempre la versione più aggiornata del software e beneficiano delle ultimissime modifiche in materia di conformità e prestazioni del sistema. Le modifiche possono essere apportate istantaneamente al sistema, senza alcuna necessità di formazione per gli utenti o di sostenere ulteriori costi di consulenza esterna.

"Dal quando abbiamo implementato Veeva CRM, abbiamo assistito a notevoli miglioramenti, tra cui: maggiore efficienza del personale impegnato sul campo, controllo più facile delle attività dei rappresentanti e migliore selezione dei clienti", conclude Goderis.    

Informazioni su Pharco Pharma NV/SA

Pharco è una società quotata in borsa (PHAR:BB) e specializzata in supplementi alimentari prescrivibili. Dal 2001 Pharco sviluppa e commercializza prodotti in Belgio e in altri Paesi europei. Per maggiori informazioni visitare http://www.pharco.be.

Informazioni su Veeva CRM

La suite di applicazioni Veeva CRM, costituita da VBioPharma, iRep, VMobile e VInsights, è la più importante soluzione CRM di tipo cloud nel settore farmaceutico e delle biotecnologie. iRep è inoltre diventata rapidamente la soluzione preferita nel settore per il Closed Loop Marketing su iPad. Solo Veeva CRM è in grado di soddisfare le specifiche esigenze di più team commerciali in un'unica soluzione, migliorando l'adozione da parte degli utenti e l'efficacia delle vendite e riducendo, allo stesso tempo, i costi e le complessità. Veeva CRM rappresenta ora la soluzione su cui l'industria farmaceutica basa i propri progetti di innovazione dei modelli di vendite e marketing futuri.

Informazioni su Veeva Systems

Veeva Systems è la società leader nel campo delle soluzioni basate sulla tecnologia cloud per il settore globale delle scienze naturali. Impegnata nell'innovazione, nell'eccellenza dei prodotti e nel successo dei clienti, Veeva vanta oltre 100 clienti, dalle aziende farmaceutiche più grandi del mondo alle società emergenti nel settore delle biotecnologie. Fondata nel 2007, Veeva è una società a capitale privato con sede nell'aera della baia di San Francisco e uffici a Filadelfia, Barcellona, Parigi, Pechino, Shanghai e Tokyo. Per maggiori informazioni, visitare http://www.veevasystems.com.

Copyright (c) 2011 Veeva Systems. Tutti i diritti riservati. Veeva e il logo Veeva sono marchi depositati di Veeva Systems. Veeva Systems possiede altri marchi depositati e non depositati. Gli altri nomi citati nel presente documento potrebbero essere marchi dei rispettivi proprietari.

Contatto per i media
Selma Nawaz
Direttore Marketing Europeo
Veeva Systems
[email protected]
+34-93-1870200

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Veeva und BioMarin schließen langfristige strategische Partnerschaft

Veeva und BioMarin schließen langfristige strategische Partnerschaft

Veeva Systems (NYSE: VEEV) und BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gaben eine langfristige Unternehmensvereinbarung bekannt, die auf ihrer...

Veeva et BioMarin forment un partenariat stratégique à long terme

Veeva et BioMarin forment un partenariat stratégique à long terme

Veeva Systems (NYSE : VEEV) et BioMarin Pharmaceutical Inc. (NASDAQ : BMRN) ont annoncé la conclusion d'un accord d'entreprise à long terme dans le...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.